Noticias de JAGX_US

Noticias del mercado

Últimas noticias sobre JAGX_US — 360 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: JAGX_US ✕ 360 resultados
08/05/2026 JAGX_US — Moomoo
Jaguar Health Regains Compliance With Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance With Nasdaq's Bid Price Rule
08/05/2026 JAGX_US — Investing.com
Jaguar Health gets extension to meet Nasdaq bid price rule
08/05/2026 JAGX_US — Stock Titan
Jaguar Health wins until May 18 to clear Nasdaq's $1 bid rule
08/05/2026 JAGX_US — GuruFocus
Jaguar Health (JAGX) Receives Nasdaq Compliance Extension
08/05/2026 JAGX_US — Yahoo Finance
Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule
08/05/2026 JAGX_US — geneonline.com
Jaguar Health Gains Nasdaq Compliance, Receives Bid Price Extension Until 2026
08/05/2026 JAGX_US — MarketScreener
Jaguar Health Regains Compliance with Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule
08/05/2026 JAGX_US — GuruFocus
Jaguar Health (JAGX) Explores Breakthrough Therapy Designation f
08/05/2026 JAGX_US — GuruFocus ES ← EN
Jaguar Health (JAGX) explora la designación de terapia innovadora f

Jaguar Health (JAGX) Explores Breakthrough Therapy Designation f

08/05/2026 JAGX_US — Moomoo
Jaguar Health Regains Compliance With Nasdaq's Publicly Held Shares Requirement and Receives Additional Extension, Until May 18, 2026, to Demonstrate Compliance With Nasdaq's Bid Price Rule
07/05/2026 JAGX_US — Stock Titan
Jaguar Health (NASDAQ: JAGX) granted short Nasdaq bid-price compliance extension
07/05/2026 JAGX_US — TipRanks
Jaguar Animal Health Granted Short Nasdaq Compliance Extension
06/05/2026 JAGX_US — TradingView
Number of shareholders of Jaguar Health, Inc. – NASDAQ:JAGX

Número de accionistas, estadísticas trimestrales y anuales de Jaguar Health, Inc..

06/05/2026 JAGX_US — Investing.com
Jaguar Health discusses breakthrough therapy path for MVID treatment By Investing.com
06/05/2026 JAGX_US — Investing.com
Jaguar Health discusses breakthrough therapy path for MVID treatment By Investing.com
06/05/2026 JAGX_US — Investing.com Canada
Jaguar Health discusses breakthrough therapy path for MVID treatment By Investing.com
06/05/2026 JAGX_US — Benzinga
Jaguar Health Stock Surges On FDA Breakthrough Discussions For Rare Disease Therapy
06/05/2026 JAGX_US — Investing.com
Jaguar Health discusses breakthrough therapy path for MVID treatment
06/05/2026 JAGX_US — Stock Titan
Drug for lethal ultrarare childhood disease enters FDA breakthrough talks
06/05/2026 JAGX_US — Yahoo Finance
Jaguar Health Announces Preliminary Discussion with FDA to Evaluate Breakthrough Therapy Designation for Crofelemer for Treatment of Microvillus Inclusion Disease (MVID)

Los pacientes pediátricos con insuficiencia intestinal (IF) debido a MVID, un trastorno congénito ultra raro con una historia natural letal, que no tiene terapias disponibles y necesita apoyo parenteral (PS) total de por vida, podrían beneficiarse del desarrollo acelerado de...

Página 7 de 18

keyboard_arrow_up